Glen Harbor Capital Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $1.54M | Buy |
12,240
+408
| +3% | +$51.5K | 0.03% | 381 |
|
|
2019
Q2 | $1.42M | Hold |
11,832
| – | – | 0.03% | 395 |
|
|
2019
Q1 | $1.04M | Buy |
11,832
+408
| +4% | +$35.7K | 0.02% | 462 |
|
|
2018
Q4 | $1.14M | Hold |
11,424
| – | – | 0.03% | 403 |
|
|
2018
Q3 | $1.31M | Buy |
11,424
+2,516
| +28% | +$288K | 0.03% | 420 |
|
|
2018
Q2 | $799K | Hold |
8,908
| – | – | 0.02% | 496 |
|
|
2018
Q1 | $652K | Hold |
8,908
| – | – | 0.01% | 541 |
|
|
2017
Q4 | $517K | Buy |
8,908
+1,530
| +21% | +$88.8K | 0.01% | 633 |
|
|
2017
Q3 | $331K | Buy |
7,378
+748
| +11% | +$33.6K | 0.01% | 732 |
|
|
2017
Q2 | $262K | Buy |
6,630
+3,060
| +86% | +$121K | 0.01% | 794 |
|
|
2017
Q1 | $145K | Hold |
3,570
| – | – | ﹤0.01% | 823 |
|
|
2016
Q4 | $143K | Buy |
+3,570
| New | +$143K | ﹤0.01% | 787 |
|